Azora Therapeutics, Inc. (AZR) Stock Overview
Explore Azora Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Azora Therapeutics, Inc. (AZR)
Key Financials
Key Financials
Market Cap
9.6M
P/E Ratio
N/A
EPS (TTM)
$-16.54
ROE
N/A
AZR Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Azora Therapeutics, Inc. (NASDAQ: AZR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Azora Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AZR on the NASDAQ shows an RSI of 40.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.
Key metrics behind Azora Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 9.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AZR on the NASDAQ.